Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Surgery Partners stock in Canada | $58.53
How to buy Surgery Partners stock in Canada | $58.53
Surgery Partners is a medical care facilities business based in the US. Surgery Partners stocks (SGRY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $61.61 – an increase of 8.65% over the previous week. Surgery Partners employs 9,100 staff and has a trailing 12-month revenue of around $1.9 billion.
How to buy Surgery Partners stock in Canada
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: SGRY in this case.
- Research Surgery Partners stocks. The platform should provide the latest information available.
- Buy your Surgery Partners stocks. It's that simple.
What's in this guide?
- Can I buy shares in Surgery Partners?
- Has coronavirus impacted Surgery Partners shares?
- Surgery Partners shares summary
- Compare share dealing platforms
- Is Surgery Partners stock a buy or sell?
- Surgery Partners performance over time
- Can I short Surgery Partners shares?
- Are Surgery Partners shares over-valued?
- Surgery Partners's financials
- How volatile are Surgery Partners shares?
- Does Surgery Partners pay a dividend?
- Other common questions
How has Coronavirus impacted Surgery Partners's stock price?
Since the stock market crash in March caused by coronavirus, Surgery Partners's stock price has had significant positive movement.
Its last market close was $58.53, which is 68.29% up on its pre-crash value of $18.56 and 1,363.25% up on the lowest point reached during the March crash when the stocks fell as low as $4.
If you had bought $1,000 worth of Surgery Partners stocks at the start of February 2020, those stocks would have been worth $319.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $3,450.93.
Surgery Partners stock priceUse our graph to track the performance of SGRY stocks over time.
Surgery Partners stocks at a glance
|Latest market close||$58.53|
|52-week range||$15.21 - $69.58|
|50-day moving average||$62.0749|
|200-day moving average||$48.4081|
|Wall St. target price||$66.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-5.044|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Surgery Partners stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Surgery Partners price performance over time
|1 month (2021-07-01)||-10.23%|
|3 months (2021-04-30)||21.43%|
Is Surgery Partners under- or over-valued?
Valuing Surgery Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Surgery Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Surgery Partners's PEG ratio
Surgery Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.66. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Surgery Partners's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Surgery Partners's EBITDA
Surgery Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$307.6 million.
The EBITDA is a measure of a Surgery Partners's overall financial performance and is widely used to measure a its profitability.
Surgery Partners financials
|Revenue TTM||USD$1.9 billion|
|Operating margin TTM||10.82%|
|Gross profit TTM||USD$379.8 million|
|Return on assets TTM||2.43%|
|Return on equity TTM||1.17%|
|Market capitalisation||USD$4.6 billion|
TTM: trailing 12 months
How to short and sell Surgery Partners stocks
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "SGRY.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 1.8 million Surgery Partners stocks held short by investors – that's known as Surgery Partners's "short interest". This figure is 14.5% down from 2.1 million last month.
There are a few different ways that this level of interest in shorting Surgery Partners stocks can be evaluated.
Surgery Partners's "short interest ratio" (SIR)
Surgery Partners's "short interest ratio" (SIR) is the quantity of Surgery Partners stocks currently shorted divided by the average quantity of Surgery Partners stocks traded daily (recently around 432188.6746988). Surgery Partners's SIR currently stands at 4.15. In other words for every 100,000 Surgery Partners stocks traded daily on the market, roughly 4150 stocks are currently held short.
However Surgery Partners's short interest can also be evaluated against the total number of Surgery Partners stocks, or, against the total number of tradable Surgery Partners stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Surgery Partners's short interest could be expressed as 0.02% of the outstanding stocks (for every 100,000 Surgery Partners stocks in existence, roughly 20 stocks are currently held short) or 0.0813% of the tradable stocks (for every 100,000 tradable Surgery Partners stocks, roughly 81 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Surgery Partners.
Find out more about how you can short Surgery Partners stock.
Surgery Partners stock dividends
We're not expecting Surgery Partners to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Surgery Partners stock price volatility
Over the last 12 months, Surgery Partners's stocks have ranged in value from as little as $15.21 up to $69.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surgery Partners's is 3.1801. This would suggest that Surgery Partners's stocks are significantly more volatile than the average for this exchange and represent a higher risk.
Surgery Partners overview
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2020, it owned or operated a portfolio of 127 surgical facilities, including 110 ambulatory surgical centers and 17 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Stocks similar to Surgery Partners
Surgery Partners in the news
Surgery Partners (SGRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Rheos Capital Works Inc. Buys Microsoft Corp, Surgery Partners Inc, Oak Street Health Inc, Sells Netflix Inc, Costco Wholesale Corp, Xilinx Inc
ClearBridge Select Strategy Portfolio Manager Commentary Q2 2021
Frequently asked questions
More guides on Finder
How to buy Wheels Up (UP) stock in Canada when it goes public
Everything we know about the Wheels Up IPO, plus information on how to buy in.
How to invest $1 million
Here are the top 5 ways you should invest $1 million.
How to buy Brookfield Asset Management Reinsurance Partners Ltd (BAMR) stock in Canada when it goes public
Everything we know about the Brookfield Asset Management Reinsurance Partners Ltd IPO, plus information on how to buy in.
How to buy Traeger (COOK) stock in Canada when it goes public
Everything we know about the Traeger IPO, plus information on how to buy in.
How to buy Teads (TEAD) stock in Canada when it goes public
Everything we know about the Teads IPO, plus information on how to buy in.
How to buy Snap One Holdings Corp (SNPO) stock in Canada
Everything we know about the Snap One Holdings Corp IPO, plus information on how to buy in.
How to buy Riskified (RSKD) stock in Canada
Everything we know about the Riskified IPO, plus information on how to buy in.
How to buy Preston Hollow Community Capital (PHCC) stock in Canada when it goes public
Everything we know about the Preston Hollow Community Capital IPO, plus information on how to buy in.
How to buy PowerSchool Holdings (PWSC) stock in Canada
Everything we know about the PowerSchool Holdings IPO, plus information on how to buy in.
How to buy MeridianLink (MLNK) stock in Canada
Everything we know about the MeridianLink IPO, plus information on how to buy in.